Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 541-552 of 4,306
Behavioral study icon
Not Yet RecruitingNCT07555275

Testing a Peer-Support Group for Veterans Who Hear Voices

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including West Los Angeles
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Device study icon
Enrolling By InvitationNCT07155096

Accelerated DMN-Targeted cTBS to Modulate DMN Connectivity

This summary needs review. Please check the official study record and contact the research team for details.

In Nashville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
Drug study icon
CompletedNCT00095524

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, United Kingdom, Brazil
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01786239

Omega-3 Dietary Supplements in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Glen Oaks
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 15 Years to 40 Years
Countries
United States
Sponsor
Delbert Robinson
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01602029

Double Blind Placebo Control Study in people with Schizophrenia

This study is completed in Pakistan. It focuses on schizophrenia.

Multiple locations, including Karachi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
Other study type icon
Enrolling By InvitationNCT01088386

Zyprexa® Relprevv™ Patient Care Program

This summary needs review. Please check the official study record and contact the research team for details.

In Blue Bell
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
United States
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN11998005

Light-dark and activity rhythm therapy for sleep: a study to explore the practicality of delivering the therapy, and participant's experiences and views of whether the intervention is acceptable, in people with schizophrenia spectrum disorders

This study is not recruiting in the United Kingdom. It focuses on schizophrenia.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherOver 18 Years
Countries
United Kingdom
Sponsor
University of Manchester
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN10917911

The effects of metacognition-oriented social skills training (MOSST) on psychosocial outcomes in schizophrenia-spectrum disorders

This study is looking at whether a digital support tool can help people with Schizophrenia spectrum disorders or Mental and Behavioural Disorders. Participants take part in a digital support tool and complete follow-up assessments.

In Spain
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Spain
Sponsor
Complejo Hospitalario of Navarra
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.